CytoDyn
(OTCQB:CYDY)
$0.34
At close: Dec 7(Delayed 15-Minutes)
Get Real Time Here
$0.3689
0.0289[8.50%]
PreMarket: 4:00PM EDT
Day Range- - -52 Wk Range0.231 - 1.300Open / Close- / -Float / Outstanding808.451M / 813.040M
Vol / Avg.0 / 1.175MMkt Cap276.434MP/E-50d Avg. Price0.390
Div / Yield (Forward)- / -%Payout Ratio-Total Float808.451MEPS-0.270

CytoDyn Stock (OTC:CYDY), Quotes and News Summary

CytoDyn Stock (OTC: CYDY) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range0.231 - 1.300Open / Close- / -Float / Outstanding808.451M / 813.040M
Vol / Avg.0 / 1.175MMkt Cap276.434MP/E-50d Avg. Price0.390
Div / Yield (Forward)- / -%Payout Ratio-Total Float808.451MEPS-0.270
Globe Newswire - Jul 13, 2022, 8:30AM
Globe Newswire - Mar 30, 2022, 8:30AM
Globe Newswire - Jan 11, 2022, 4:35PM
Globe Newswire - Dec 10, 2021, 3:59PM
Seeking Alpha - Jun 13, 2022, 6:04PM
InvestorsObserver - Jun 10, 2022, 12:29PM
InvestorsObserver - May 11, 2022, 10:44AM
InvestorsObserver - May 3, 2022, 9:56AM
InvestorsObserver - Apr 8, 2022, 1:31PM
Seeking Alpha - Mar 30, 2022, 3:52PM
InvestorsObserver - Feb 9, 2022, 9:56AM
InvestorsObserver - Jan 10, 2022, 8:52AM
Seeking Alpha - Jan 7, 2022, 3:20AM
Seeking Alpha - Dec 18, 2021, 6:54AM
Sector: Health Care.Industry: Biotechnology
CytoDyn Inc is a US-based clinical-stage biotechnology company which focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The lead product candidate is PRO 140, which is a class of HIV therapy called entry inhibitors that block HIV from entering into and infecting certain cells. The company emphasizes exploring opportunities for clinical applications for PRO 140 involving the CCR5 (C-C chemokine receptor type 5) receptor, other than HIV-related treatments, such as inflammatory conditions, autoimmune diseases, and cancer.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy CytoDyn (CYDY) stock?

A

You can purchase shares of CytoDyn (OTCQB: CYDY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CytoDyn's (CYDY) competitors?

A

There are no as such competitors for CytoDyn.

Q

What is the target price for CytoDyn (CYDY) stock?

A

The latest price target for CytoDyn (OTCQB: CYDY) was reported by HC Wainwright & Co. on Monday, July 6, 2020. The analyst firm set a price target for 0.00 expecting CYDY to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for CytoDyn (CYDY)?

A

The stock price for CytoDyn (OTCQB: CYDY) is $0.34 last updated December 7, 2022, 8:58 PM UTC.

Q

Does CytoDyn (CYDY) pay a dividend?

A

There are no upcoming dividends for CytoDyn.

Q

When is CytoDyn (OTCQB:CYDY) reporting earnings?

A

CytoDyn does not have any upcoming earnings scheduled.

Q

Is CytoDyn (CYDY) going to split?

A

There is no upcoming split for CytoDyn.

Q

What sector and industry does CytoDyn (CYDY) operate in?

A

CytoDyn is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.